231 related articles for article (PubMed ID: 34862215)
41. Bronchiectasis in Childhood.
Goyal V; Chang AB
Clin Chest Med; 2022 Mar; 43(1):71-88. PubMed ID: 35236563
[TBL] [Abstract][Full Text] [Related]
42. Bronchiectasis in rheumatoid arthritis. A clinical appraisial.
Duarte AC; Porter J; Leandro MJ
Joint Bone Spine; 2020 Oct; 87(5):419-424. PubMed ID: 32007647
[TBL] [Abstract][Full Text] [Related]
43. Managing and preventing exacerbation of bronchiectasis.
Abo-Leyah H; Chalmers JD
Curr Opin Infect Dis; 2020 Apr; 33(2):189-196. PubMed ID: 31990814
[TBL] [Abstract][Full Text] [Related]
44. Lung transplantation for non-cystic fibrosis bronchiectasis.
Rademacher J; Ringshausen FC; Suhling H; Fuge J; Marsch G; Warnecke G; Haverich A; Welte T; Gottlieb J
Respir Med; 2016 Jun; 115():60-5. PubMed ID: 27215505
[TBL] [Abstract][Full Text] [Related]
45. Airway clearance techniques for bronchiectasis.
Lee AL; Burge A; Holland AE
Cochrane Database Syst Rev; 2013 May; (5):CD008351. PubMed ID: 23728674
[TBL] [Abstract][Full Text] [Related]
46. [Multidisciplinary Management of Non-cystic-fibrosis Bronchiectasis - State of the Art].
Mertsch P; Merhej H; Zardo P
Zentralbl Chir; 2021 Jun; 146(3):346-358. PubMed ID: 34154019
[TBL] [Abstract][Full Text] [Related]
47. British Thoracic Society guideline for non-CF bronchiectasis.
Pasteur MC; Bilton D; Hill AT;
Thorax; 2010 Jul; 65(7):577. PubMed ID: 20627912
[No Abstract] [Full Text] [Related]
48. [Non-cystic fibrosis bronchiectasis [corrected]].
Ringshausen FC; Rademacher J; Welte T
Dtsch Med Wochenschr; 2014 Apr; 139(14):707-10. PubMed ID: 24668431
[No Abstract] [Full Text] [Related]
49. The role of macrolides in childhood non-cystic fibrosis-related bronchiectasis.
Masekela R; Green RJ
Mediators Inflamm; 2012; 2012():134605. PubMed ID: 22570510
[TBL] [Abstract][Full Text] [Related]
50. Antimicrobial treatment of non-cystic fibrosis bronchiectasis.
Grimwood K; Bell SC; Chang AB
Expert Rev Anti Infect Ther; 2014 Oct; 12(10):1277-96. PubMed ID: 25156239
[TBL] [Abstract][Full Text] [Related]
51. Should the bronchiectasis treatment given to cystic fibrosis patients be extrapolated to those with bronchiectasis from other causes?
Athanazio RA; Rached SZ; Rohde C; Pinto RC; Fernandes FL; Stelmach R
J Bras Pneumol; 2010; 36(4):425-31. PubMed ID: 20835588
[TBL] [Abstract][Full Text] [Related]
52. The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas aeruginosa Infection in Non-cystic Fibrosis Bronchiectasis.
Dhand R
J Aerosol Med Pulm Drug Deliv; 2018 Jun; 31(3):121-138. PubMed ID: 29077527
[TBL] [Abstract][Full Text] [Related]
53. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
Rogers GB; Bruce KD; Martin ML; Burr LD; Serisier DJ
Lancet Respir Med; 2014 Dec; 2(12):988-96. PubMed ID: 25458200
[TBL] [Abstract][Full Text] [Related]
54. Airway clearance techniques for bronchiectasis.
Lee AL; Burge AT; Holland AE
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD008351. PubMed ID: 26591003
[TBL] [Abstract][Full Text] [Related]
55. Spanish Guidelines on Treatment of Bronchiectasis in Adults.
Martínez-García MÁ; Máiz L; Olveira C; Girón RM; de la Rosa D; Blanco M; Cantón R; Vendrell M; Polverino E; de Gracia J; Prados C
Arch Bronconeumol (Engl Ed); 2018 Feb; 54(2):88-98. PubMed ID: 29128129
[TBL] [Abstract][Full Text] [Related]
56. Management of Australian Adults with Bronchiectasis in Tertiary Care: Evidence-Based or Access-Driven?
Visser SK; Bye PTP; Fox GJ; Burr LD; Chang AB; Holmes-Liew CL; King P; Middleton PG; Maguire GP; Smith D; Thomson RM; Stroil-Salama E; Britton WJ; Morgan LC
Lung; 2019 Dec; 197(6):803-810. PubMed ID: 31691027
[TBL] [Abstract][Full Text] [Related]
57. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.
Bilton D; Henig N; Morrissey B; Gotfried M
Chest; 2006 Nov; 130(5):1503-10. PubMed ID: 17099030
[TBL] [Abstract][Full Text] [Related]
58. Non-cystic fibrosis bronchiectasis.
Murray MP; Hill AT
Clin Med (Lond); 2009 Apr; 9(2):164-9. PubMed ID: 19435127
[No Abstract] [Full Text] [Related]
59. Prevention of exacerbations in patients with stable non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis of pharmacological and non-pharmacological therapies.
Abu Dabrh AM; Hill AT; Dobler CC; Asi N; Farah WH; Haydour Q; Wang Z; Benkhadra K; Prokop LJ; Murad MH
BMJ Evid Based Med; 2018 Jun; 23(3):96-103. PubMed ID: 29678900
[TBL] [Abstract][Full Text] [Related]
60. Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis.
Chalmers JD; Boersma W; Lonergan M; Jayaram L; Crichton ML; Karalus N; Taylor SL; Martin ML; Burr LD; Wong C; Altenburg J
Lancet Respir Med; 2019 Oct; 7(10):845-854. PubMed ID: 31405828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
